Avantika Medex Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.03 Cr
as on 16-11-2024
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.03 Cr
as on 16-11-2024
- Satisfied Charges ₹ 11.08 Cr
as on 16-11-2024
- Revenue -26.84%
(FY 2023)
- Profit -42.54%
(FY 2023)
- Ebitda -105.83%
(FY 2023)
- Net Worth 16.17%
(FY 2023)
- Total Assets -4.47%
(FY 2023)
About Avantika Medex
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.03 Cr.
The company currently has active open charges totaling ₹11.03 Cr. The company has closed loans amounting to ₹11.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
Lal Singh and Vibha Singh serve as directors at the Company.
- CIN/LLPIN
U51397GJ2007PTC082606
- Company No.
082606
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Avantika Medex Private Limited offer?
Avantika Medex Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Bath Soaps, Pharmaceutical Tablets, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Sexual Wellness Products, Female Hygiene Products & Test Kits, Cosmetics, Skin Care Cosmetics, Antipyretic Medication.
Who are the key members and board of directors at Avantika Medex?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lal Singh | Director | 18-Sep-2007 | Current |
Vibha Singh | Director | 18-Sep-2007 | Current |
Financial Performance of Avantika Medex.
Avantika Medex Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.84% decrease. The company also saw a substantial fall in profitability, with a 42.54% decrease in profit. The company's net worth Soared by an impressive increase of 16.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Avantika Medex?
Unlock access to Avantika Medex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Avl Life Science Private LimitedActive 11 years 6 months
Lal Singh and Vibha Singh are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 29 Dec 2023 | ₹9.90 Cr | Open |
Axis Bank Limited Creation Date: 15 Dec 2022 | ₹9.31 M | Open |
Hdfc Bank Limited Creation Date: 05 Feb 2014 | ₹2.00 M | Open |
How Many Employees Work at Avantika Medex?
Unlock and access historical data on people associated with Avantika Medex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avantika Medex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avantika Medex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.